Labcorp Holdings Inc. financial data

Symbol
LH on NYSE
Industry
Services-Medical Laboratories
Location
358 S Main St, Burlington, NC
Fiscal year end
December 31
Former names
LABORATORY CORP OF AMERICA HOLDINGS (to 5/16/2024), NATIONAL HEALTH LABORATORIES HOLDINGS INC (to 2/13/1995)
Latest financial report
10-Q - Q3 2024 - Oct 29, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 107 % -35.6%
Quick Ratio 12.8 % -25.6%
Debt-to-equity 114 % +12%
Return On Equity 5.44 % -23.7%
Return On Assets 2.54 % -28.1%
Operating Margin 5.88 % -16.4%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 83.6M shares -1.49%
Common Stock, Shares, Outstanding 83.7M shares -1.41%
Entity Public Float 17.3B USD -14.4%
Common Stock, Value, Issued 7.6M USD -1.3%
Weighted Average Number of Shares Outstanding, Basic 84M shares -3%
Weighted Average Number of Shares Outstanding, Diluted 84.4M shares -2.99%

Income Statement

Label TTM Value / Value Unit Change %
Revenues 12.7B USD +12.5%
Cost of Revenue 9.16B USD +13%
Operating Income (Loss) 747M USD -5.89%
Income Tax Expense (Benefit) 192M USD +54.3%
Net Income (Loss) Attributable to Parent 436M USD -34.1%
Earnings Per Share, Basic 5.31 USD/shares -30.5%
Earnings Per Share, Diluted 5.27 USD/shares -30.6%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 1.52B USD +108%
Accounts Receivable, after Allowance for Credit Loss, Current 2.06B USD +5.19%
Inventory, Net 483M USD +4.77%
Assets, Current 4.91B USD +24.2%
Deferred Income Tax Assets, Net 0 USD -100%
Property, Plant and Equipment, Net 3.05B USD +8.14%
Operating Lease, Right-of-Use Asset 737M USD -0.14%
Intangible Assets, Net (Excluding Goodwill) 3.54B USD +8.09%
Goodwill 6.48B USD +2.38%
Other Assets, Noncurrent 613M USD +34.2%
Assets 18.6B USD +10.2%
Accounts Payable, Current 661M USD -4.3%
Employee-related Liabilities, Current 431M USD -2.97%
Accrued Liabilities, Current 758M USD +9.83%
Liabilities, Current 3.41B USD +17.6%
Operating Lease, Liability, Noncurrent 701M USD +5.87%
Other Liabilities, Noncurrent 528M USD +24.9%
Liabilities 10.4B USD +15.9%
Accumulated Other Comprehensive Income (Loss), Net of Tax -113M USD +45.8%
Retained Earnings (Accumulated Deficit) 8.28B USD +2.56%
Stockholders' Equity Attributable to Parent 8.17B USD +3.77%
Liabilities and Equity 18.6B USD +10.2%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -29.8M USD -125%
Net Cash Provided by (Used in) Financing Activities -11.7M USD +80.7%
Net Cash Provided by (Used in) Investing Activities -393M USD -294%
Common Stock, Shares Authorized 265M shares 0%
Common Stock, Shares, Issued 83.9M shares -4.88%
Common Stock, Par or Stated Value Per Share 0.1 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -438M USD -1112%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 1.93B USD +97.3%
Deferred Tax Assets, Valuation Allowance 150M USD -0.73%
Deferred Tax Assets, Gross 795M USD +15.8%
Operating Lease, Liability 815M USD -0.25%
Payments to Acquire Property, Plant, and Equipment 134M USD +71.1%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent 531M USD -45.6%
Lessee, Operating Lease, Liability, to be Paid 962M USD -6.08%
Property, Plant and Equipment, Gross 5.82B USD +8.15%
Operating Lease, Liability, Current 184M USD +13.6%
Lessee, Operating Lease, Liability, to be Paid, Year One 200M USD -6.06%
Operating Lease, Weighted Average Discount Rate, Percent 0.04 pure +27.8%
Deferred Income Tax Expense (Benefit) -19.5M USD -172%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 148M USD -7.4%
Deferred Tax Assets, Operating Loss Carryforwards 247M USD +2.07%
Preferred Stock, Shares Authorized 30M shares 0%
Unrecognized Tax Benefits 29.9M USD -20.3%
Preferred Stock, Shares Outstanding 0 shares
Amortization of Intangible Assets 245M USD +30.2%
Depreciation, Depletion and Amortization 155M USD +8.73%
Deferred Tax Assets, Net of Valuation Allowance 645M USD +20.5%
Interest Expense 194M USD -3.05%
Preferred Stock, Par or Stated Value Per Share 0.1 USD/shares 0%